Anne‐Gaëlle Dosne

Improving the estimation of parameter uncertainty distributions in nonlinear mixed effects models using sampling importance resampling

Anne‐Gaëlle Dosne, Martin Bergstrand, Kajsa Harling et al. · Journal of Pharmacokinetics and Pharmacodynamics · 2016 · 245 citations · Full text

An automated sampling importance resampling procedure for estimating parameter uncertainty

Anne‐Gaëlle Dosne, Martin Bergstrand, Mats O. Karlsson · Journal of Pharmacokinetics and Pharmacodynamics · 2017 · 140 citations · Full text

Erdafitinib (ERDA; JNJ-42756493), a pan-fibroblast growth factor receptor (FGFR) inhibitor, in patients (pts) with metastatic or unresectable urothelial carcinoma (mUC) and <i>FGFR</i> alterations (FGFRa): Phase 2 continuous versus intermittent dosing.

Yohann Loriot, Andrea Necchi, Se Hoon Park et al. · Journal of Clinical Oncology · 2018 · 28 citations

Immunology, Fgfra Muc, Unresectable Urothelial Carcinoma +18

dOFV distributions: a new diagnostic for the adequacy of parameter uncertainty in nonlinear mixed-effects models applied to the bootstrap

Anne‐Gaëlle Dosne, Ronald Niebecker, Mats O. Karlsson · Journal of Pharmacokinetics and Pharmacodynamics · 2016 · 14 citations · Full text

Population Pharmacokinetics of Total and Free Erdafitinib in Adult Healthy Volunteers and Cancer Patients: Analysis of Phase 1 and Phase 2 Studies

Anne‐Gaëlle Dosne, Elodie Valade, Kim Stuyckens et al. · The Journal of Clinical Pharmacology · 2019 · 13 citations